Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$507K Sell
3,458
-235
-6% -$42.6K 0.04% 229
2026
Q1
$543K Sell
3,693
-280
-7% -$45.5K 0.04% 221
2025
Q4
$774K Buy
3,973
+33
+0.8% +$7.86K 0.06% 199
2025
Q3
$1.11M Sell
3,940
-123
-3% -$31.3K 0.09% 165
2025
Q2
$888K Sell
4,063
-223
-5% -$36K 0.08% 174
2025
Q1
$599K Buy
4,286
+307
+8% +$50K 0.06% 204
2024
Q4
$663K Hold
3,979
0.06% 194
2024
Q3
$678K Sell
3,979
-950
-19% -$138K 0.07% 185
2024
Q2
$696K Sell
4,929
-35
-0.7% -$4.35K 0.08% 177
2024
Q1
$624K Sell
4,964
-110
-2% -$12.6K 0.08% 174
2023
Q4
$535K Sell
5,074
-91
-2% -$9.93K 0.07% 174
2023
Q3
$547K Buy
5,165
+1,586
+44% +$184K 0.07% 182
2023
Q2
$426K Sell
3,579
-195
-5% -$20.2K 0.06% 174
2023
Q1
$351K Sell
3,774
-127
-3% -$11.1K 0.06% 182
2022
Q4
$319K Sell
3,901
-754
-16% -$57.3K 0.06% 185
2022
Q3
$284K Buy
4,655
+1,100
+31% +$80.5K 0.07% 194
2022
Q2
$248K Sell
3,555
-38
-1% -$2.78K 0.07% 190
2022
Q1
$297K Buy
3,593
+1,137
+46% +$92.1K 0.07% 184
2021
Q4
$214K Buy
2,456
+135
+6% +$12.7K 0.06% 207
2021
Q3
$202K Buy
+2,321
New +$205K 0.07% 197

Other funds holding ORCL

CGN Advisors's ORCL Position: Q2 2026 in Review

CGN Advisors reduced its Oracle (ORCL) stake by 6.4% in Q2 2026, selling an estimated $42.6K and leaving 3,458 shares worth $507K. The position accounts for 0.04% of the portfolio, ranked #229.

CGN Advisors first reported a position in ORCL in Q3 2021 and has held it in 20 quarters since. The position peaked at $1.11M in Q3 2025. 1,681 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • CGN Advisors held 3,458 shares of Oracle worth $507K as of Q2 2026.
  • CGN Advisors sold 235 Oracle shares in Q2 2026, an estimated $42.6K.
  • Oracle made up 0.04% of CGN Advisors's portfolio in Q2 2026, its #229 holding.
  • CGN Advisors first reported a position in Oracle in Q3 2021 and has held it in 20 quarters since.
  • CGN Advisors's Oracle position peaked at $1.11M in Q3 2025.
  • 1,681 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on CGN Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.